偉志控股(01305.HK)將於明日刊發去年度未經審覈全年業績
偉志控股(01305.HK)公佈,由於中國若幹城市的新冠疫情預防和控制隔離措施的實施,致使公司截至2021年12月底止年度的審覈程序受到延阻,包括但不限於公司核數師無法按時獲得於中國相關地區銀行的審計詢證函,公司核數師將需要更多時間完成審覈程序。公司認爲將無法根據上市規則於3月31日前刊發集團去年度的經審覈全年業績。
此外,公司決定於明日(25日)根據集團2021財政年度的管理賬目刊發集團2021財政年度的未經審覈全年業績,公司之審覈委員會將審閱該2021年未經審覈全年業績。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.